STOCK TITAN

XCF Global insider buys warrants for 6.9M shares

XCF Global, Inc. (SAFX) reported that GL Part SPV II, LLC, an affiliate of a 10% owner, acquired warrants on September 14, 2026 to purchase 6,891,798 shares of Series A Common Stock at an exercise price of $2.50 per share.

(Very High)
(Very Positive)
Form Type
4

Rhea-AI Filing Summary

XCF Global, Inc. (SAFX) reported that GL Part SPV II, LLC, an affiliate of a 10% owner, acquired warrants on September 14, 2026 to purchase 6,891,798 shares of Series A Common Stock at an exercise price of $2.50 per share. These warrants are currently held directly by the reporting entity and are scheduled to expire on September 30, 2029; the reported post-transaction warrant position is 6,891,798 underlying shares.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider GL Part SPV II, LLC
Role Insider
Bought 6,891,798 shs ($17.23M)
Type Security Shares Price Value
Purchase Warrant to purchase Series A Common Stock 6,891,798 $2.50 $17.23M
Holdings After Transaction: Warrant to purchase Series A Common Stock — 6,891,798 contracts (Direct)
Warrant shares acquired 6,891,798 warrants (underlying 6,891,798 shares) Derivative purchase reported for September 14, 2026
Exercise price $2.50 per share Conversion or exercise price of warrant for Series A Common Stock
Expiration date September 30, 2029 Reported expiration date of the warrant position
Post-transaction derivative holdings 6,891,798 underlying shares Total shares underlying warrants after the reported transaction
Warrant financial
"Warrant to purchase Series A Common Stock"
A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.
Series A Common Stock financial
"underlying security title is Series A Common Stock"
Series A common stock is a specific class of a company’s ordinary shares issued during an early formal funding round, carrying the ownership rights and voting power tied to that class. For investors it signals an early-stage equity claim with potential upside if the business grows, but also greater risk and typically less liquidity than shares in mature, publicly traded firms—imagine buying a seat on a startup’s team before the company has proven itself.
expiration date financial
"expiration date of the warrant is September 30, 2029"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SAFX report in this Form 4?

XCF Global, Inc. reported that GL Part SPV II, LLC acquired a warrant to purchase 6,891,798 shares of Series A Common Stock on September 14, 2026, in a derivative transaction classified as a purchase.

What is the exercise price of the warrants reported for SAFX?

The warrants reported for XCF Global, Inc. (SAFX) have an exercise price of $2.50 per share for the underlying Series A Common Stock, based on the filed conversion or exercise price and transaction price fields.

How many SAFX shares are underlying the acquired warrants?

The acquired warrant position is exercisable for 6,891,798 shares of XCF Global, Inc. Series A Common Stock, and the total derivative position following the transaction remains at the same 6,891,798 underlying shares.

When do the reported SAFX warrants expire?

The warrants to purchase XCF Global, Inc. (SAFX) Series A Common Stock are reported with an expiration date of September 30, 2029, defining the final date by which they may be exercised under the terms reported.

Is the SAFX Form 4 transaction under a Rule 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox as not affirmed (false), and there is no footnote stating the warrant purchase was made pursuant to a Rule 10b5-1 or similar pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GL Part SPV II, LLC

(Last)(First)(Middle)
30 N GOULD ST., STE R

(Street)
SHERIDAN WYOMING 82801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
XCF Global, Inc. [ SAFX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
Officer (give title below)XOther (specify below)
Affiliate of 10% owner
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant to purchase Series A Common Stock$2.509/14/2026P6,891,79809/14/202609/30/2029Series A Common Stock6,891,798$2.56,891,798D
Explanation of Responses:
Majique Ladnier09/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading